Health Sciences Institute e-Alert Archives

Our daily e-letter, known as e-Alert, delivers health news—before anyone else. From overlooked studies to underground cures, it’s all here. Catch up on the insights that matter most.

Every weekday, our FREE e-Alert delivers urgent health breakthroughs and hidden dangers—before they hit the headlines.

Not signed up yet? Join 500,000+ readers worldwide by using the sign-up box below.

FILTERS
applied to search results for “Cancer”

YEAR

CATEGORY

Browse the FULL e-Alert Archive using the filters in this section, or search for a specific topic below:


Search Results for “Cancer” (3324 results found)

This treatment will prevent “chemobrain.” So why will some doctors howl against it?

February 19, 2013 Chemobrain treatments during chemotherapy may cause doctors to howl. Don't mind the noise. Research shows that antioxidant therapy can protect the brain AND enhance chemotherapy... Read More >

Categories: antioxidants chemo brain Chemobrain chemotherapy cognitive impairment glutathione IAA intravenous ascorbic acid intravenous nutritional therapies n-acetyl cysteine NAC oncologists vitamin C

This shocking chemotherapy side effect can last for decades

February 18, 2013 "Chemobrain" is more formally known as "post-chemotherapy cognitive impairment" (PCCI). This side effect can last for decades, but some doctors have never heard of it... Read More >

Categories: blood brain barrier brain blood flow brain metabolism chemo brain Chemobrain chemotherapy PCCI post-chemotherapy cognitive impairment toxic

Don’t pop even one more aspirin until you read this urgent warning

February 6, 2013 Don't pop even one more aspirin until you read this urgent warning. New research implies aspirin therapy may cut dementia risk. In fact, aspirin use can boost severe risks in older patients... Read More >

Categories: Alzheimer's Disease aspirin dangers aspirin therapy bleeding brain cognitive function dementia gastrointestinal memory loss

The report that Campbell’s is phasing out BPA is way off the mark

February 4, 2013 The report that Campbell's is phasing out BPA is way off the mark. In fact, the global soup giant has actually embraced its commitment to stay with BPA lining in billions of cans produced yearly... Read More >

Categories: 2015 bisphenol A BPA breast cancer Campbell's Soup Food Production Daily Forbes heart disease neurological disorders phase out prostate cancer science type 2 diabetes

How do you like your salmon? Normal? Or Frankensalmon?

January 29, 2013 How do you like your salmon? Normal? Or Frankensalmon? Unfortunately, you may not get a choice if the FDA decides to approve a genetically engineered salmon... Read More >

Categories: allergens antibiotics cancer promoting hormone environmental assessment FDA GE Genetically engineered public comments salmon seafood industry

Women who use sleep aids are at greater risk than men

January 24, 2013 Women who use sleep aids are at greater risk of side effects than men, so the FDA has ordered changes to recommended dosage. But will it be enough to save their lives... Read More >

Categories: Ambien BMJ British Medical Journal dosage change FDA hypnotic Lunesta risk of death sleeping pills women

The most popular weight-loss drug is even more dangerous than we thought

January 21, 2013 The most popular weight-loss drug is even more dangerous than we thought. That drug is Alli. And potential organ failure (liver, kidney, pancreas) is just part of the problem... Read More >

Categories: Alli anticlotting aspirin cancer drugs FDA inhibit fat absorption kidney failure liver failure pancreatic failure Weight Loss Xenical
Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >